New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News For AMZN;BA;CHK;MERU;BIOC;CPNO;KMP;ISIS;MTOR;NOC;PLXT;HNT;CODE From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
<< 1 | 2 | 3 | 4 | 5 | all recent news | >>
March 23, 2015
16:35 EDTCHKChesapeake lowers FY15 CapEx view to $3.5B-$4B from $4B-$4.5B
Subscribe for More Information
16:01 EDTAMZNOptions Update; March 23, 2015
iPath S&P 500 VIX Short-Term Futures down 48c to 25.24 Option volume leaders: AAPL TSLA TWTR GILD CELG FB TSLA AMZN TEVA PBR according to Track Data.
16:00 EDTAMZNAmazon adds Pandora-like stations to Prime Music app, The Verge reports
Subscribe for More Information
09:11 EDTAMZNAmazon 'Unlocked' to give away paid apps, TechCrunch says
Subscribe for More Information
08:53 EDTAMZNAmazon VP and General Manager of Payments departs, TechCrunch says
Subscribe for More Information
08:13 EDTAMZNPendrell unit: Court rejects attempts to limit scope of DRM patents
ContentGuard Holdings, a subsidiary of Pendrell Corporation (PCO), announced that on Friday, March 20, Judge J. Rodney Gilstrap of the U.S. District Court for the Eastern District of Texas issued a 144 page Claim Construction Order in lawsuits ContentGuard filed against several companies who continue to use its patented Digital Rights Management solutions without a license, including Apple (AAPL), Amazon.com (AMZN), DirecTV (DTV), Google (GOOG), HTC, Huawei, Motorola Mobility and Samsung Electronics (SSNLF). In his order, Judge Gilstrap interpreted the language in ContentGuard’s patents in a manner that fully preserves the breadth of ContentGuard’s patented Digital Rights Management technologies. These technologies were developed to enable the distribution of digital media over the Internet and other networks, including cellular and satellite networks, and provide innovative solutions to problems that were once thought to be unsolvable. “We are very pleased with the Court’s ruling,” commented James Baker, ContentGuard’s Vice President for Licensing and Strategic Development. “We believe these claim constructions demonstrate that the online stores defendants provide for buying and renting DRM-protected movies, videos, books, and music and devices that play, run, display or print this DRM-protected content infringe ContentGuard’s pioneering DRM patents.”
08:13 EDTBA, NOCBofA/Merrill airlines/aerospace analysts hold analyst/industry conference call
Subscribe for More Information
08:01 EDTNOC, BABofA/Merrill industrials/EU autos analysts hold analyst/industry conference call
Analysts provide a discussion of the key takeaways from the recently held Global Industrials & European Autos Conference on an Analyst/Industry conference call. to be held on March 23 at 10 am.
07:04 EDTISISIsis Pharmaceuticals says ISIS-ANGPTL3Rx 'well tolerated' in Phase 1 study
Isis Pharmaceuticals announced positive results from a Phase 1 study with ISIS-ANGPTL3Rx. In this study, healthy volunteers treated with ISIS-ANGPTL3Rx achieved dose-dependent, statistically significant reductions in angiopoietin-like 3 of up to 93% with a mean reduction of up to 84% from baseline. In addition, statistically significant reductions from baseline in lipid parameters were observed, including up to 63% with a mean reduction of up to 49% in triglycerides and up to 46% with a mean reduction of up to 28% in total cholesterol. ANGPTL3 is a protein that acts as a key regulator of these blood lipids. These data were presented at the 83rd European Atherosclerosis Society in Glasgow, United Kingdom. The Phase 1 study of ISIS-ANGPTL3Rx was a blinded, placebo-controlled, dose-escalation study in healthy volunteers. The study was designed to assess the safety, tolerability and pharmacokinetics of ISIS-ANGPTL3Rx. ISIS-ANGPTL3Rx was evaluated in single and multiple doses ranging from 50 mg per week up to 400 mg per week for the single dose and 100 mg per week up to 400 mg per week for the multiple dose. In this study, ISIS-ANGPTL3Rx was generally well tolerated.
05:55 EDTAMZNStocks with implied volatility movement; AMZN CELG
Subscribe for More Information
March 20, 2015
11:45 EDTISISIsis Pharmaceuticals management to meet with Needham
Subscribe for More Information
10:43 EDTCHKStocks with call strike movement; CHK FCX
Chesapeake (CHK) July 16 call option implied volatility increased 2% to 50, Freeport McMoRan (FCX) August 20 call option implied volatility decreased 6% to 47 according to IVolatility.
09:45 EDTAMZNActive equity options trading on open
Subscribe for More Information
09:02 EDTNOCUS Air Force Sustainment Center and Northrop enter into partnership agreement
Subscribe for More Information
08:18 EDTHNTLeerink healthcare services analyst holds an analyst/industry conference call
Healthcare Services Analyst Gupte discusses Sustainable Growth Rate (SGR) and the proposed pay-fors and implications For Healthcare Services on an Analyst/Industry conference call to be held on March 20 at 11 am.
March 19, 2015
16:31 EDTAMZNAmazon Logistics UAS gets experimental airworthiness certificate
Subscribe for More Information
16:10 EDTNOCNorthrop Grumman wins recompete for DISA task order
Northrop Grumman has been awarded a task order by the Defense Information Systems Agency, or DISA, to continue its lead role on the Acropolis and Sensor Operations program - a capability that protects DISA-managed networks from cyber-attack and provides global cyber situational awareness for these networks. The award is worth up to $73.6M over four years.
10:12 EDTHNTHealth Net to reaffirm FY15 EPS guidance 'at least' $2.70
Subscribe for More Information
10:02 EDTMTOR, CHKOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
09:20 EDTCHKOn The Fly: Pre-market Movers
Subscribe for More Information
<< 1 | 2 | 3 | 4 | 5 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use